Andere Sprachen SUSMED,Inc.

Aktien

A3DGDB

JP3319150003

4263

Verzögert Japan Exchange Andere Börsenplätze 07:27:27 20.05.2024			% 5 Tage	% 1. Jan.
571 ^JPY	+3,25 %		+4,20 %	-57,23 %

2022	Walgreens Boots Alliance, Inc. tritt der Partnerschaft für nachhaltige Arzneimittel bei	CI
2022	Aculys Pharma und SUSMED schließen einen Vertrag über die Durchführung einer klinischen Studie mit Hilfe der Blockchain-Technologie	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index	18.09.23
SUSMED’s DTx Approved in Japan for the Treatment of Insomnia	25.08.23
Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership	04.10.22
Aculys Pharma and SUSMED Have Entered into a Contract to Conduct the World's First Clinical Trial Utilizing Blockchain Technology	13.07.22
Aculys Pharma and SUSMED Enter into A Contract to Conduct the Clinical Trial Utilizing Blockchain Technology	13.07.22
Certain Common Stock of SUSMED,Inc. are subject to a Lock-Up Agreement Ending on 21-JUN-2022.	21.06.22
Certain Common Stock of SUSMED,Inc. are subject to a Lock-Up Agreement Ending on 23-MAR-2022.	23.03.22
CollaboCreate Co., Ltd. announced that it has received funding from SUSMED,Inc.	10.03.22
Shionogi Signs up to $41 Million Commercialization Contract for Insomnia App	28.12.21
Shionogi & Co., Ltd. Announces Commercialization Agreement with SUSMED Co., Ltd. for Digital Therapeutic App for Insomnia	27.12.21
SUSMED,Inc. has completed an IPO in the amount of ¥3.65613 billion.	24.12.21
SUSMED,Inc. has filed an IPO.	19.11.21
SUSMED Co., Ltd. announced that it has received funding from Suzuken Co., Ltd.	30.10.20
SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.	27.10.20
SUSMED Co., Ltd. announced that it has received ¥200 million in funding from Sumitomo Corporation	25.08.20
SUSMED Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.	11.05.20
SUSMED Co., Ltd. announced that it has received ¥720 million in funding from Tokyo Century Corporation, M3, Inc., SBI Investment Co., Ltd., Beyond Next Ventures Inc., Sony Innovation Fund, The Dai-Ichi Life Insurance Company, Limited	04.06.18

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Sichern und steigern Sie die Performance Ihrer Investitionen - mit unserem Expertenteam an Ihrer Seite.

Meine Investitionen sichern

fermer